Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.

MLA

Imthurn, B., et al. “Differential Effects of Hormone-Replacement Therapy on Endogenous Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted with 17 Beta-Estradiol Valerate and Cyproterone Acetate or Medroxyprogesterone Acetate.” The Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 2, Feb. 1997, pp. 388–94. EBSCOhost, https://doi.org/10.1210/jcem.82.2.3780.

APA

Imthurn, B., Rosselli, M., Jaeger, A. W., Keller, P. J., & Dubey, R. K. (1997). Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate. The Journal of Clinical Endocrinology and Metabolism, 82(2), 388–394. https://doi.org/10.1210/jcem.82.2.3780

Chicago

Imthurn, B, M Rosselli, A W Jaeger, P J Keller, and R K Dubey. 1997. “Differential Effects of Hormone-Replacement Therapy on Endogenous Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted with 17 Beta-Estradiol Valerate and Cyproterone Acetate or Medroxyprogesterone Acetate.” The Journal of Clinical Endocrinology and Metabolism 82 (2): 388–94. doi:10.1210/jcem.82.2.3780.